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Summary Growth factor activity which stimulates anchorage-independent growth (AIG) in a rat fibroblast
line, was detected in human premalignant adenoma tissue from familial polyposis coli colectomy specimens
and in serum-free culture supernatant from an adenoma cell line PC/AA. The activity extracted from
adenoma tissue was compared quantitatively in the AIG bioassay with extracts of normal mucosa from split
thickness colorectal tissue. Adenoma tissue yielded three times the amount of acid-extractable protein g-1 wet
wt and adenoma extracts consistently had significantly greater specific activity over a wide protein
concentration range. Activity extracted from adenoma tissue and from the derived cell line PC/AA were
compared qualitatively after fractionation by gel filtration. Both extracts showed almost identical profiles of
biological activity after assay of individual fractions for AIG stimulation, suggesting that the factor(s)
originates from the epithelial component of the adenoma tissue since PC/AA is a pure epithelial cell line.
Activity eluted as two major peaks with apparent mol. wts of 9kd and 20-25kd (relative to standards) in
both cases. This report demonstrates for the first time that elevated production of a growth factor may be an
early change in the evolution of human colorectal cancer from small, premalignant adenomas.
It is now generally accepted that many human
tumours and transformed cells in vitro produce
growth factors aberrantly (Scott Goustin et al.,
1986). Amongst these are the well-defined tumour
or transforming growth factors (TGFs). One key
property of TGFs and TGF-like factors, acting
either alone or synergistically, is their ability to
stimulate the anchorage-independent growth (AIG)
of cells in semi-solid agar medium which normally
require a solid substrate in order to divide. Since
AIG is a constitutive property of many malignant
cells, its induction by factors from tumour cells is
of obvious interest to cancer biologists. TGF-like
activity is not detectable in most normal tissues, but
there are notable exceptions eg. placenta
(Stromberg et al., 1982).
Very few studies have been reported which are
directed at pre-cancerous tissues or cells (see De
Cosse, 1983 for definitions), to determine whether
these have already acquired the ability to express
TGF activity and if so, at what stage in multistage
carcinogenesis does TGF activity become apparent.
An earlier report from our laboratory attempted to
investigate these questions using mouse epithelial
cells transformed in vitro (Wigley et al., 1985).
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We have been interested primarily in progression
of premalignant tissues towards malignancy in
human colon and rectum, where the adenoma-
carcinoma sequence is well documented (reviewed
in Morson et al., 1983). A source of premalignant
colorectal tissue available to us through
collaboration with St. Mark's Hospital, London,
was from colorectal anastomosis surgery on
patients with the inherited cancer-prone condition,
familial polyposis coli or adenomatosis of the colon
and rectum. Although this condition is rare, there
are good grounds for thinking that the multiple
small adenomas in young polyposis patients are
equivalent in their biological properties and suscep-
tibility to malignant progression, to those arising
sporadically in later life in the general population
(Morson et al., 1983). Additionally, small, early-
stage sporadic adenomas are rarely available for
research in quantity in a predictable fashion. We
thus adopted polyposis adenoma tissue as a model
for colon premalignancy in general. Further
description of the material obtained and character-
isation of epithelial cell lines derived from pre-
malignant adenomas is given by Paraskeva et al.
(1984).
The present study undertook to compare normal
and premalignant cells and tissues from human
colon and rectum for the presence of TGF-like
activity in an assay for stimulation of AIG in a rat
fibroblast cell line, used by us previously (Wigley et
al., 1985). We report the first finding of elevated
levels of growth factor activity in extracts of early
(in terms of its malignant potential) adenoma tissue
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and in serum-free culture supernatants (SFS) of one
of the adenoma lines established in our laboratory
(Paraskeva et al., 1984).
Materials and methods
Cell cultures and SFS collection
The premalignant adenoma cell line PC/AA and the
colon carcinoma line PC/JW were grown and sub-
cultured as described by Paraskeva et al. (1984) and
used between passages 6 and 12. In some experi-
ments cells were plated directly onto plastic instead
of collagen-coated plastic as is usual for these lines.
Cultures were grown to confluence in complete
growth medium, taking 2-3 weeks. By this time
they were essentially free of the mitomycin-C
treated 3T3 feeder cells used to support growth at
low density after subculture. Up to 10 replicate
5cm petri dishes of confluent cells were used for
each batch of SFS. Cultures were washed
extensively with serum-free Dulbecco's modified
Eagle's medium (DMEM) and incubated in the
same for several hours or overnight. This was
discarded and replaced with 2.5ml fresh serum-free
DMEM per dish which was collected after 48h and
replaced again. The procedure was repeated at 48h
intervals for as long as the cells remained healthy
and attached to the substrate, generally about a week
(i.e., three serial collections). Individual batches
(one collection) were made 1 M with respect to acetic
acid and acid-insoluble material precipitated over-
night at 4°C (Wigley et al., 1985). Precipitate was
removed by centrifugation at 20,000r.p.m. and the
supernatant dialysed exhaustively against 1 M acetic
acid in Spectrophor tubing (cut-off 3,500kdmol.wt,
Spectrum Medical Industries, LA, USA) at 4°C.
The retentate was shell frozen, lyophilised to dryness
and stored at -70°C.
Tissue specimens
All colorectal tissue specimens were obtained from
St. Mark's Hospital, London. Normal tissues were
removed surgically during operative procedures for
a variety of non-malignant conditions not associ-
ated with an increased cancer risk. These included
diverticular disease and chronic constipation.
Tissues were processed either as whole bowel wall
thickness specimens or, in later experiments, as
mucosa or submucosa and muscle split thicknesses,
separated mechanically. The level of separation was
confirmed histologically for each specimen. Pre-
cancerous adenomas were obtained from colectomy
specimens following ileorectal anastomosis in
patients with familial polyposis coli. Individual
adenomas were removed from the mucosal surface
with scissors and pooled from each patient in
washing medium on ice as described by Paraskeva
et al. (1984) for transport to the laboratory.
Representative samples of adenomas from each
pool were processed for histology and the histo-
pathological diagnoses compared with those from
St. Mark's.
Tissue extraction
Tissues were extracted in acid ethanol according to
the procedure of Stromberg et al. (1982), which was
modified from Roberts et al. (1980) for the
isolation of TGF activity from solid tissues. Briefly,
tissue was minced and homogenised in 2mlg- I of a
mixture of 95% ethanol and 2% hydrochloric acid
(by vol), containing 0.008% phenylmethylsulfonyl-
fluoride. The volume was adjusted to 3mlg-1 with
the addition of distilled water and tissue was
extracted at 4°C overnight. After centrifugation at
8,000r.p.m. for 2h, the pH of the supernatant was
adjusted to 5.2 with ammonium hydroxide and 2M
ammonium acetate buffer (pH=5.2) added to 1%
(by vol). The resultant precipitate was removed by
centrifugation at 20,000r.p.m. for 30min and the
supernatant precipitated with precooled ether (4vol)
and ethanol (2vol) at -20°C for 24h. The precipi-
tate was washed twice with cold ethanol and
dissolved in 1 M acetic acid. The solution was
dialysed exhaustively against 1 M acetic acid at 4°C
in Spectraphor tubing (cutt-off mol. wt=3,500kd),
shell frozen, lyophilised to dryness and stored at
-700C.
Bioassayfor anchorage-independent growth (AIG)
stimulating activity
All measurements of biological activity of tissue
extracts and culture supernatants were performed
as described previously (Wigley et al., 1985) using
Rat 1 fibroblasts as indicator cells and 0.3% agar
in DMEM containing 10% newborn calf serum
(controls) with the addition of unfractionated or
fractionated lyophilised tissue extracts or culture
supernatants reconstituted in DMEM as described
in Results. Assays were scored after 7-10 days in
most cases but, where necessary, dishes were fed
with a further aliquot of test agar medium at 7days
and were scored at 14 days. Colonies greater than
about 60 cells were counted using an eyepiece
graticule. Triplicate counts of colonies cm-2 were
made from each ofduplicate dishes in most cases.
Biogel gelfiltration chromatography
A 2.2 x 90cm column of P60 Biogel (Biorad) was
equilibrated with 1 M acetic acid and calibrated with
mol. wt markers as described, previously (Wigley etGROWTH FACTORS FROM COLORECTAL ADENOMAS 801
al., 1985) and as shown in the figure legends.
Samples of lyophilised tissue extract or cell culture
SFS were reconstituted in 3-5ml 1M acetic acid,
insoluble material removed by centrifugation where
necessary and the supernatant applied to the
column which was developed by upward elution in
1 M acetic acid at 4°C. Two to 4ml fractions were
collected, OD280 recorded on each and shell frozen,
lyophilised to dryness and stored at -70°C for
bioassay.
Results
Cell culture SFS activity
During the establishment of the premalignant
epithelial cell line PC/AA, derived from a single
adenoma in a polyposis coli patient (Paraskeva et
al., 1984) we assayed crude SFS from a number of
early passage (8-12) cultures for the presence of
TGF-like activity using Rat 1 indicator cells in
semi-solid agar medium. We found that SFS was
consistently highly active in inducing Rat I colonies
in agar. These appeared within one week, grew
rapidly and were induced at high frequency. When
freshly collected SFS from PC/AA was included in
the agar assay at a 1:2 or 1:4 dilution, we obtained
reproducible 30-50 fold increases in background
colony formation. The results of one experiment
with passage 10 SFS diluted 1:4 in agar were as
follows. Control plates showed an average of
4.5+1.5 (s.d.) Rat 1 colonies cm 2 (n =6)
compared with SFS-treated plates with 174+3
(s.d.) colonies cm 2 (n=3). In this experiment, the
PC/AA cells from which SFS was collected were
grown in the absence of collagen although in other
experiments this improved the attachment of cells
in serum-free conditions.
Interestingly, SFS from the carcinoma-derived
cell line PC/JW (Paraskeva et al., 1984) showed
consistently lower activity than PC/AA although
this was still significantly greater than background.
In the same assay experiment as PC/AA passage 10
SFS (above), PC/JW passage 6 SFS gave 65+21
(s.d.) Rat 1 colonies cm 2 (n=6). These were also
smaller colonies generally, creating some difficulty
in scoring, hence the high standard deviation.
Tissue activity
At this time PC/AA cells were in limited supply
since they grew very slowly and were needed for
characterisation experiments (Paraskeva et al.,
1984). Also, in our hands, the normal mucosal
epithelium from patients with conditions other than
malignancy or polyposis, remains difficult to grow
continuously, or even to confluence in primary
culture. We therefore attempted to determine
whether production of TGF-like activity was a
feature of premalignant, as compared with normal
mucosal epithelium by assaying acidic extracts of
tissues for biological activity. Figure 1 shows histo-
logical sections through representative samples of
each type of tissue. Figure la shows normal mucosa
separated mechanically at about the level of the
muscularis mucosae which is absent in this prepar-
ation but occasionally stayed with the mucosal
layers. Figure lb shows a section through a typical
small (-0.5cm2) adenoma from a young polyposis
, -0 -:..
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Figure 1 Histological sections of paraffin-embedded
tissues representative of those used for growth factor
extraction, stained with haematoxylin and eosin. (a)
Normal colon mucosa, separated mechanically from its
submucosa and muscle showing that separation is at
about the level of the muscularis mucosae, which is
missing from this specimen. (b) Tubular adenoma,
showing mild dysplasia, from a 15 year old male
polyposis coli patient undergoing colectomy and
ileorectal anastomosis. Bars represent 100pm.
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coli patient. It is a tubular adenoma showing only
mild dysplasia and would be considered
pathologically as an early stage premalignant tissue
with low potential for malignant change. By
definition, adenoma tissue does not extend beyond
the muscularis mucosae and so should be
comparable in this respect with the normal mucosa
samples.
Biological activity was compared between acidic
extracts of normal and premalignant adenoma
tissues in the AIG-stimulation assay described
above. Table I compares the biological activities of
three separate extracts of adenoma tissue from
polyposis colectomy specimens (all small, tubular
adenomas from young individuals) with normal
mucosal tissue from three colon specimens resected
for non-malignant conditions (see Materials and
methods). At similar protein concentrations (taken
from dose-response curve data; protein measured
colorimetrically (Biorad)), the adenoma tissue
extracts showed significantly higher specific activity
than the normal tissue extracts. A further two
normal specimens yielded negligible amounts of
soluble protein g-1 wet weight and showed no
biological activity detectable above background
levels.
Figure 2 shows the results obtained from one
pair of extracts prepared strictly in parallel from
the same initial wet weights of tissue. It is clear that
over a wide protein concentration range, the
adenoma tissue showed greater TGF-like biological
activity than its normal counterpart. Most normal
tissue samples analysed were, in fact, less active still
(see Table I). The difference between the two tissue
extracts illustrated in Figure 2 was further enhanced
when account was taken of the total amount of
acid-extractable protein recovered from equivalent
wet weights of tissue. The amounts of soluble
protein in the lyophilised material were 0.42mgg-1
and 1.3mgg-' for the normal and premalignant
tissues respectively, i.e., there was a three-fold
higher recovery of acid-extractable protein g-1 of
the adenoma tissue. Differences of this order were
observed consistently although preparations were
done at different times over a period of a year.
Separation ofactivity by gelfiltration
chromatography
Adenoma tissue is composed of both premalignant
epithelium and its stroma, which we considered
might show reactive change and be sufficiently
different metabolically from its normal counterpart
lamina propria to account for the differences seen
above. One approach to the question of whether
the observed TGF-like activity originated in the
epithelium or the stroma would be to compare the
characteristics of this tissue TGF with that from the
Table I Biological activity of adenoma and normal
mucosa tissue extracts
Protein Agar
Experiment concentration colonies
number (ugml-) cm-2a
Adenoma 1 ND TMTCb
2c 49 242.0+20.0
3 70 189.0+19.0
Normal mucosa 1 60 14.0+ 3.5
2c 48 53.0+ 16.0
3 69 32.5+ 4.3
Data is shown for three separate tissue extracts in each
group, assayed at similar protein concentrations. aMean
value (n =3-6)+ s.d. The background value (tissue extract
omitted) has been subtracted in each case; bTMTC =too
many to count. In this first experiment, undiluted
adenoma extract was used; Cdata taken from the
experiment presented in Figure 2.
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Figure 2 Comparison between extracts of polyposis
coli adenoma tissue and normal mucosa for activity in
the anchorage-independent growth stimulation assay
using Rat 1 fibroblast indicator cells. Numbers of
colonies >60 cells were scored cm-2 using an eyepiece
graticule, 7-10 days after seeding single cells in various
concentrations of extracted protein in 0.3% agar
medium, as described in Materials and methods and
previously (Wigley et al., 1985). Protein concentrations
were measured colorimetrically (Biorad) with reference
to transferrin standard. Counts were made from three
fields, in each of duplicate dishes and standard
deviations from the means shown by vertical bars.GROWTH FACTORS FROM COLORECTAL ADENOMAS 803
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Figure 3 Fractionation by P60 Biogel gel filtration
chromatography of an acid-ethanol extract of 2g of
adenoma tissue from a polyposis coli patient as
described in Materials and methods. The sample was
applied in 3ml 1 M acetic acid and 3.9ml fractions
collected. Absorbance at 280nm was recorded on each
and every third fraction was assayed for stimulation of
anchorage-independent growth of Rat 1 cells as
described for Figure 2. Half of the fraction was
included in the agar mixture in each of two separate
assay experiments which were in very good agreement.
The histogram bars represent means of duplicate
counts from one of the assay experiments. Results are
plotted against elution volume and the elution
positions of standard proteins fractionated under
identical conditions are shown by vertical arrows
above. Vo=void volume, CA=carbonic anhydrase
(Mr=29,000), RNase=ribonuclease A (Mr= 13,900),
I =Insulin (Mr=6,000).
cell line PC/AA which consists purely of pre-
malignant colon epithelial cells (Paraskeva et al.,
1984). We chose to compare the profiles of activity
after separation of proteins by gel filtration
according to molecular size, after elution in 1M
acetic acid from a Biogel P60 column. Figure 3
shows that the adenoma tissue activity fractionates
as two major peaks with apparent mol. wts (Mr) of
21 kd and 9kd. The majority of the protein eluted
in the void volume and only a small protein peak
was coincident with the high Mr peak of activity.
Figure 4 shows the equivalent data for acid-
extracted SFS from cell line PC/AA. Again two
main peaks of activity are seen at comparable size
positions (relative to standard proteins) as in Figure
3. A broad peak (or doublet of peaks) has an Mr
of 20-25kd and a second sharper peak of activity
eluted at Mr=9kd. In this case also, the great
majority of the protein was larger in size and eluted
at or just beyond the void volume (estimated at
35kd in the acid conditions of our system).
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Figure 4 Fractionation of acid-ethanol extracted
serum-free supernatant from the adenoma-derived
epithelial cell line PC/AA prepared as described in
Materials and methods from three serial collections
from 5 replicate 5cm dishes of confluent cells. Fiveml
of lyophilised extract in 1 M acetic acid were applied to
the column and 3.25ml fractions collected. Assays and
evaluation of fractions was otherwise exactly as
described for Figure 3.
Discussion
In our studies on the progression of human colo-
rectal epithelial cells from the normal to the
malignant phenotype, we have been particularly
interested in characteristics which distinguish the
premalignant cells from both their normal and
cancerous counterparts. The inherited cancer-prone
condition, familial polyposis coli, has been
invaluable as a model for colorectal cancer in
general (see Introduction), because of the availability
of early stage premalignant adenoma tissue from
colectomy specimens. In this report we show that
adenoma tissue from polyposis coli patients yielded
acid soluble protein extracts with high activity in an
assay for TGF function, stimulating AIG in an
anchorage-dependent fibroblast line. This cell line,
like many others but unlike the rather atypical
NRK cells, does not respond to ,B-NGF but is
stimulated by a number of known growth factors
(discussed in Wigley et al., 1984). To the best of
our knowledge, this is the first report demon-
strating TGF-like activity in colorectal adenomas
although colon adenocarcinoma tissue and cell lines
have proven positive (Nickell et al., 1983; Coffey et
al., 1986). Specific activities were significantly
higher over a wide dose range than in similar
extracts from normal colon mucosa, most of which
0
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were essentially inactive, and the total yields of
extractable protein were, additionally, several fold
higher from the adenoma tissue. No attempt was
made to investigate 'normal' mucosa from
polyposis colectomy specimens. Not only was this
difficult to dissect cleanly, it shows a high incidence
of microscopic glandular abnormality and thus
cannot be considered normal. It is apparent from
Figure 1 that the adenoma tissue contained a
higher proportion of epithelium. We consider that
this factor was unlikely to account for the observed
differences in both the total amount of acid-
extractable protein and its specific activity.
The indicator fibroblast colonies stimulated to
grow in agar appeared after less than one week and
grew rapidly to a large size without requiring the
presence of other factors such as epidermal growth
factor. In contrast, the control assay colonies
(which varied in frequency somewhat depending on
the length of time the stock of indicator fibroblasts
cells had been subcultured continuously) were
almost always at the lower size limit of -60 cells.
Although colony diameter was the parameter
assessed, control colonies consisted of bigger, more
loosely packed cells and so cell number may have
been considerably less than estimated.
Interestingly, although the normal mucosa
extracts were almost inactive, extracts of the
separated muscle and submucosal layers, deep to
the muscularis mucosae, possessed high activity
(data not shown), comparable in specific activity to
the adenoma tissue. The muscle TGF-like activity
completely accounted in fact, for the positive results
obtained in early AIG-stimulation assays with
extracts of whole thickness normal colon. Whether
the premalignant cell growth factor is similar to or
different from the activity from normal muscle and
submucosal tissue is not clear and will require
further detailed analysis. No attempts were made to
fractionate the low levels of activity from normal
mucosa and it is possible that this (since variable)
could have originated from contaminating sub-
mucosal or muscle tissues.
We have evidence, however, of similarities in one
respect between adenoma tissue extract and
factor(s) extractable from the SFS of an adenoma
epithelial cell line, PC/AA. The elution profiles of
biological activity from both sources after gel
filtration analysis were remarkably similar with
major peaks at - 9 and just over 20kd. It must be
remembered though that size estimates from this
type of analysis should be regarded as useful for
comparative purposes only and are not intended to
represent true values. This has been discussed in an
earlier report (Wigley et al., 1985). The activity
profiles from premalignant colon tissue and cells
differed considerably from the TGF-like activity
described by Wigley et al. (1985) from transformed
mouse epithelial cells, fractionated and assayed
using identical sysems.
The results obtained from fractionation experi-
ments strengthen the view that the adenoma tissue
activity is a product of premalignant epithelium
(rather than deriving from a stromal component)
because of its similarity to activity from the purely
epithelial, adenoma-derived cell line. The results
also suggest that the factor(s) is secreted since
activity is recovered from tissue culture supernatant
in the absence of observable cell lysis. The
carcinoma-derived cell line PC/JW from the same
series (Paraskeva et al., 1984) also produces similar
TGF activity in SFS, but to a lesser extent than
PC/AA. The other two adenoma lines described in
that report have not yet been tested. As with crude
extracts and SFS, column fractions stimulated AIG
in the absence of other added factors. All active
samples and fractions also stimulated DNA
synthesis in quiescent, serum-starved 3T3 cells in
the mitogenesis assay described previously (Wigley
et al., 1985). This effect was less marked though
than the AIG-stimulating activity (unpublished
data), in contrast to the earlier study on mouse
cells.
A possible explanation for our results is that the
TGF-like activity is associated with actively
proliferating cells and that these represent a bigger
fraction of the adenoma tissue. If so, then this
relationship no longer holds for the carcinoma cells
of the PC/JW line, which has a much greater
clonogenic population and shorter doubling time
than the adenoma line, PC/AA. It is tempting to
draw a parallel here with a recent study (Williams
et al., 1985) showing higher levels of p21 ras
oncogene protein expression in colon adenomas
than in either normal or adenocarcinoma tissue.
There have been a number of similar studies
reaching somewhat conflicting conclusions (e.g.,
Thor et al., 1984; Kerr et al., 1985) but since we
have no evidence connecting our findings with
altered oncogene expression, such comparisons are
purely speculative. Alternatively, the factor could
represent a neuropeptide precursor released
aberrantly from neuroendocrine cells differentiating
within the adenoma tissue, as has been described
for colonic adenocarcinomas (Ulich et al., 1983).
In conclusion, we demonstrate that a potent
biologically active factor with functional similarities
to the TGF family, is released from early-stage,
premalignant colorectal tissue. The activity could
potentially serve as a marker of an early stage in
carcinogenesis in screening tests on, for example,
faecal samples from high risk individuals. MuchGROWTH FACTORS FROM COLORECTAL ADENOMAS 805
remains to be determined though before such ideas
could be developed in practice. We anticipate that
an approach using monoclonal antibodies raised
against peak activity column fractions and screened
in a function-blocking agar assay, will be most
useful in determining the nature, cell of origin and
expression pattern of the adenoma growth factor
identified here.
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